Vanguard Capital Management’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$234K Buy
870,714
+55,800
+7% +$15.5K ﹤0.01% 3774
2026
Q2
$222K Buy
814,914
+96,478
+13% +$28.5K ﹤0.01% 3810
2026
Q1
$189K Buy
+718,436
New +$199K ﹤0.01% 3804

Other funds holding IGC

Vanguard Capital Management's IGC Position: Q3 2026 in Review

Vanguard Capital Management increased its IGC Pharma (IGC) stake by 6.8% in Q3 2026, buying an estimated $15.5K and bringing the position to 870,714 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #3774.

Vanguard Capital Management first reported a position in IGC in Q1 2026 and has held it in 3 quarters since. 29 funds tracked by Wall St. Rank hold IGC as of Q3 2026.

  • Vanguard Capital Management held 870,714 shares of IGC Pharma worth $234K as of Q3 2026.
  • Vanguard Capital Management bought 55,800 IGC Pharma shares in Q3 2026, an estimated $15.5K.
  • IGC Pharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3774 holding.
  • Vanguard Capital Management first reported a position in IGC Pharma in Q1 2026 and has held it in 3 quarters since.
  • 29 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.